PDS Biotechnology Corp Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross
PDS Biotechnology Corp (PDSB) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross of 63.80 thousand shares for the 3-month period ending 2021-09-30, per its 10-Q filed 2021-11-10.
Discontinued › Shareholders' Equity
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross · last filed 2021-11-10
- PDS Biotechnology Corp share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2021-09-30 was 63.80K shares.
- PDS Biotechnology Corp share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2021-06-30 was 1.39M shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 6 month |
|---|---|---|
| 2021-09-30 | 63.80K shares 10-Q · filed 2021-11-10 | 1.45M shares derived: sum of 2 quarters · filed 2021-11-10 |
| 2021-06-30 | 1.39M shares 10-Q · filed 2021-08-12 | 1.66M shares 10-Q · filed 2021-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| VERU INC. (VERU) | United States | $0.043B | -3.93 |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |